NCT03027531

Brief Summary

This study is a randomized controlled trial to test acceptability, feasibility and preliminary efficacy of an interactive computer-based intervention with individualized feedback to promote sexual health in adolescents and young adults with assessment of behavioral and biomarker outcomes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
272

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2013

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 23, 2017

Completed
Last Updated

January 24, 2017

Status Verified

January 1, 2017

Enrollment Period

1.4 years

First QC Date

January 19, 2017

Last Update Submit

January 20, 2017

Conditions

Keywords

reproductive health, condoms, sexually transmitted diseases, contraception

Outcome Measures

Primary Outcomes (1)

  • Unprotected sex (no condoms) from self-report via computerized survey

    number of unprotected sex events when participant did not use condom during sex

    during last 2 months (asked at 3 month follow-up visit)

Secondary Outcomes (3)

  • Unprotected sex (no birth control) from self-report via computerized survey

    during last 2 months (asked at the 3-month follow-up visit)

  • Number of sex partners from self-report via computerized survey

    during last 2 months (asked at the 3-month follow-up visit)

  • Biomarkers: urine sample tested with nucleic acid amplification test for STDs and urine sample pregnancy test

    over last 3 months (asked at the 3-month follow-up visit)

Study Arms (2)

Control

EXPERIMENTAL

Control group entered sexual history via computer assisted self-interview and provided specimens for chlamydia, gonorrhea and pregnancy(females) testing. The do not receive the feedback intervention of eKISS: electronic KIOSK for safer-sex

Behavioral: eKISS: electronic KIOSK for Safer-Sex

Intervention

EXPERIMENTAL

Intervention group entered sexual history via computer assisted self-interview and received the interactive computer-based intervention with individualized feedback eKISS: electronic KIOSK for safer-sex. They provided specimens for chlamydia, gonorrhea and pregnancy(females) testing.

Behavioral: eKISS: electronic KIOSK for Safer-Sex

Interventions

An interactive computer-based intervention for safer-sex which provides individualized feedback about protective and risky sexual behaviors; offers instructive video modules for safe-sex; elicits change behavior and identification of behavior change goal using elements of motivational interviewing.

ControlIntervention

Eligibility Criteria

Age14 Years - 24 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English speaking and reading
  • Report at least one episode of unprotected vaginal sex (no condom OR no birth control) in the last 2 months
  • Not currently pregnant or actively seeking pregnancy in self or partner

You may not qualify if:

  • Currently pregnant or actively seeking pregnancy in self or partner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Reproductive BehaviorSexually Transmitted Diseases

Condition Hierarchy (Ancestors)

BehaviorCommunicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Taraneh Shafii, MD, MPH

    University of Washington

    PRINCIPAL INVESTIGATOR
  • King K Holmes, MD, PhD

    University of Washington; Center for AIDS and STD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Pediatrics, Division of Adolescent Medicine

Study Record Dates

First Submitted

January 19, 2017

First Posted

January 23, 2017

Study Start

February 1, 2012

Primary Completion

June 30, 2013

Study Completion

June 30, 2013

Last Updated

January 24, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share